 - Phase I: Patients receive high-dose cytarabine IV over 3 hours followed by clofarabine IV over 2 hours on days 1-5. Treatment repeats for up to 4 courses 1-2 induction courses, 2-3 post-remission courses in the absence of disease progression or unacceptable toxicity. 